Key findings from the 2026 study include: Within six months of starting GLP-1 therapy, the rate of hypotensive events rose from 8.7% to 10.2%
The mechanisms are well established: Reduced cardiac output
Sometimes, these are linked to changes in the body's hormones
Pi-Sunyer, X., Astrup, A., Fujioka, K., Greenway, F., Halpern, A., Krempf, M.,
The study was conducted in accordance with the Declaration of Helsinki of 1964 and its later amendments and International Council for Harmonisation (ICH) Good Clinical Practice guidelines
Our team of professionals will guide you through each step, from consultation to personalized treatment planning